No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Leerink Partners Maintains Pliant Therapeutics(PLRX.US) With Buy Rating, Maintains Target Price $33
Positive Developments in Pliant Therapeutics' IPF Research Bolster Buy Rating
Pliant Therapeutics Reports Increased Losses and Strategic Focus
Pliant Therapeutics Plans To Present Data From Bexotegrast Program At Liver Meeting 2024